Table 2 Trichomonas vaginalis seropositive status and diagnosis of aggressive prostate cancer
From: A prospective study of Trichomonas vaginalis and prostate cancer risk among African American men
Diagnosis of aggressive PCa | ||||
|---|---|---|---|---|
Gleason < 7 | Gleason ≥ 7 | OR | 95 % CI | |
n | 74 | 101 | ||
Mean (SD) | 0.25 (0.10) | 0.26 (0.10) | ||
Serostatus | ||||
Negative | 60 (81.1 %) | 80 (79.2 %) | ||
Positive | 14 (18.9 %) | 21 (20.8 %) | 1.04 | 0.48–2.26 |
Stage 0–1 | Stage 2–4 | |||
|---|---|---|---|---|
n | 230 | 40 | ||
Mean (SD) | 0.25 (0.12) | 0.26 (0.10) | ||
Serostatus | ||||
Negative | 179 (77.8 %) | 30 (75.0 %) | ||
Positive | 51 (22.2 %) | 10 (25.0 %) | 1.23 | 0.55–2.74 |